Explore
Everything on GPcardio.org in one place: lectures, updates and the literature scan.
TRIUMPH-2Amylin in MilanAcute Coronary Syndrome in Kawasaki Disease From Infancy to Adulthood.Heart failure with a preserved ejection fractionTRANSCEND-T2D-1CKMSurvival benefit of deceased donor kidney transplantation versus continued dialysisPerioperative management of SGLT2 inhibitors
Optimising Management with SGLT-2i-based Strategies in Primary Care
The Foundation of Cardiorenal Protection: What the Guidelines Say
Cardiorenal Risk Management at the Interface of Primary Care and Cardiology
EU Screening Week - Know Your Numbers CampaignWomen's Kidney Health in FocusGlucosuria as a Marker of Adherence to Sodium-Glucose Cotransporter 2 Inhibitors and Clinical Outcomes in Real-World Practice.A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for Lipid Management for Cardiovascular Disease Risk Reduction.Postpartum HypertensionCatheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF)
Stroke Insights – Connecting science and lived experienceImpact of nonsteroidal mineralocorticoid receptor antagonism on cardiorenal outcomes in diabetic kidney diseaseDevice-detected atrial fibrillation after ARTESiA and NOAH-AFNET 6The 2025 AHA/ACC Hypertension GuidelinesEfficacy and safety of canagliflozin are consistent across polypharmacy burden in CKDInflammation as a therapeutic target to improve kidney and cardiovascular outcomes.From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals.Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep ApneaDipeptidyl Peptidase-4 Inhibitors Associated Heart Failure Events in Adult Patients With Type-2 Diabetes Mellitus Treated With Dipeptidyl Peptidase-4 InhibitorsAdverse pregnancy outcomes and long-term cardiovascular riskPerformance of estimated glomerular filtration rate equations across ethnic groups in the AIM CKD UK cohortMapping the modifiable exposome for ischemic strokeCKD; New ESC Guidelines: Every Patient with Heart Disease Should Now Be Tested for Kidney DiseaseComplications of Transcatheter Aortic Valve ReplacementPaediatric-to-adult transition in inherited arrhythmia syndromes.Wearable wrist-watch type cuff oscillometric blood pressure monitorsGlucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness.Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records.Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial FibrillationWalking a tightropeACASA-TAVIThe clinician as patientTRIC-I-HFTIME-HFMyocardial Infarction: A New Universal DefinitionBeyond LDL-CSTAREELIBREXIA ACSSWITCH SWEDEHEARTAMUNDSENAIR-STEMIPREMIUMA-CLOSEEPIDAURUSREACTNew Data Confirms Adherence Is Key to Blood Pressure ControlCARDIO-TTRansformSINGLE-AFNew 2026 ESC guideline on cardiovascular disease and chronic kidney diseaseCMR GUIDEFifth Universal Definition of Myocardial InfarctionFirst ESC guideline on cardiac rehabilitationACACIA-HCM
Optimising Management with SGLT-2i-based Strategies in Primary CareThe Foundation of Cardiorenal Protection: What the Guidelines SayCardiorenal Risk Management at the Interface of Primary Care and CardiologyEU Screening Week - Know Your Numbers CampaignWomen's Kidney Health in FocusGlucosuria as a Marker of Adherence to Sodium-Glucose Cotransporter 2 Inhibitors and Clinical Outcomes in Real-World Practice.A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for Lipid Management for Cardiovascular Disease Risk Reduction.Postpartum HypertensionCatheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF)Stroke Insights – Connecting science and lived experienceImpact of nonsteroidal mineralocorticoid receptor antagonism on cardiorenal outcomes in diabetic kidney diseaseDevice-detected atrial fibrillation after ARTESiA and NOAH-AFNET 6The 2025 AHA/ACC Hypertension GuidelinesEfficacy and safety of canagliflozin are consistent across polypharmacy burden in CKDInflammation as a therapeutic target to improve kidney and cardiovascular outcomes.From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals.Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep ApneaDipeptidyl Peptidase-4 Inhibitors Associated Heart Failure Events in Adult Patients With Type-2 Diabetes Mellitus Treated With Dipeptidyl Peptidase-4 InhibitorsAdverse pregnancy outcomes and long-term cardiovascular riskPerformance of estimated glomerular filtration rate equations across ethnic groups in the AIM CKD UK cohortMapping the modifiable exposome for ischemic strokeCKD; New ESC Guidelines: Every Patient with Heart Disease Should Now Be Tested for Kidney DiseaseComplications of Transcatheter Aortic Valve ReplacementPaediatric-to-adult transition in inherited arrhythmia syndromes.Wearable wrist-watch type cuff oscillometric blood pressure monitorsGlucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness.Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records.Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial FibrillationWalking a tightropeACASA-TAVIThe clinician as patientTRIC-I-HFTIME-HFMyocardial Infarction: A New Universal DefinitionBeyond LDL-CSTAREELIBREXIA ACSSWITCH SWEDEHEARTAMUNDSENAIR-STEMIPREMIUMA-CLOSEEPIDAURUSREACTNew Data Confirms Adherence Is Key to Blood Pressure ControlCARDIO-TTRansformSINGLE-AFNew 2026 ESC guideline on cardiovascular disease and chronic kidney diseaseCMR GUIDEFifth Universal Definition of Myocardial InfarctionFirst ESC guideline on cardiac rehabilitationACACIA-HCMNothing found. Try another word or remove a filter.